https://www.biopharmawatch.com/news/MODD/modular-medical-webinar-launch-pivot BiopharmaWatch en 2026-09-04T00:00:00.000Z Registration is Now Open for Tribe Public's CEO Presentation and Q&A Webinar Event Titled ''The Road To Revenue: Modular Medical's Strategy For Launching Pivot'' Featuring Modular Medical CEO - Friday, September 4, 2026 https://www.biopharmawatch.com/news/RVP/retractable-technologies-supports-onsore-manufacturing-act BiopharmaWatch en 2026-09-03T21:25:00.000Z Retractable Technologies, Inc. Supports Senator Blackburn’s ONSHORE Manufacturing Act https://www.biopharmawatch.com/news/CTKB/cytek-biosciences-spectral-flow-cytometry-escca-iccs BiopharmaWatch en 2026-09-03T21:00:00.000Z Cytek® Biosciences Highlights the Expanding Role of Spectral Flow Cytometry in Clinical Research at ESCCA and ICCS https://www.biopharmawatch.com/news/TDOC/teladoc-health-inducement-awards-cfo BiopharmaWatch en 2026-09-03T20:35:00.000Z Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08 https://www.biopharmawatch.com/news/DBVT/dbv-technologies-september-investor-conferences BiopharmaWatch en 2026-09-03T20:32:00.000Z DBV Technologies to Participate in Upcoming September Investor Conferences https://www.biopharmawatch.com/news/BIAF/bioaffinity-technologies-hc-wainwright-conference BiopharmaWatch en 2026-09-03T20:30:00.000Z bioAffinity Technologies to Participate in the H.C. Wainwright 28th Annual Global Investment Conference https://www.biopharmawatch.com/news/GMED/globus-medical-ce-mark-excelsius3d-imaging-system BiopharmaWatch en 2026-09-03T20:30:00.000Z Globus Medical Announces CE Mark for Excelsius3D™ Imaging System https://www.biopharmawatch.com/news/IQV/iqvia-predictive-clinical-development-efficiencies BiopharmaWatch en 2026-09-03T20:15:00.000Z IQVIA's Predictive Clinical Development Provides Sponsors With Significant Efficiencies to Get Treatments to Market Faster https://www.biopharmawatch.com/news/VANI/vivani-medical-investor-conferences-2026 BiopharmaWatch en 2026-09-03T20:08:00.000Z Vivani Medical Announces Participation in Upcoming Investor Conferences https://www.biopharmawatch.com/news/AGMB/agomab-participate-investor-conferences-september-2026 BiopharmaWatch en 2026-09-03T20:05:48.000Z Agomab to Participate in Upcoming Investor Conferences https://www.biopharmawatch.com/news/ALEC/alector-participate-upcoming-healthcare-conferences BiopharmaWatch en 2026-09-03T20:05:00.000Z Alector to Participate in Upcoming Healthcare Conferences https://www.biopharmawatch.com/news/IRWD/ironwood-participate-wells-fargo-healthcare-conference BiopharmaWatch en 2026-09-03T20:05:00.000Z Ironwood Pharmaceuticals to Participate in the Wells Fargo 21st Annual Healthcare Conference https://www.biopharmawatch.com/news/CNTB/connect-biopharma-hc-wainwright-conference-2026 BiopharmaWatch en 2026-09-03T20:05:00.000Z Connect Biopharma to Present at the H.C. Wainwright 28th Annual Global Investment Conference https://www.biopharmawatch.com/news/KTTA/pasithea-therapeutics-september-2026-investor-conferences BiopharmaWatch en 2026-09-03T20:05:00.000Z Pasithea Therapeutics Announces Participation in Two September 2026 Investor Conferences https://www.biopharmawatch.com/news/IMRX/immuneering-participate-investor-conferences BiopharmaWatch en 2026-09-03T20:05:00.000Z Immuneering to Participate in Upcoming Investor Conferences https://www.biopharmawatch.com/news/PCVX/vaxcyte-appoints-cmo-and-clo-narrows-vax-31-data-guidance BiopharmaWatch en 2026-09-03T20:05:00.000Z Vaxcyte Appoints Chief Medical Officer and Chief Legal Officer; Narrows Guidance for Expected VAX-31 OPUS-1 Topline Data https://www.biopharmawatch.com/news/CV/capsovision-participate-upcoming-investor-conferences BiopharmaWatch en 2026-09-03T20:05:00.000Z CapsoVision to Participate in Upcoming Investor Conferences https://www.biopharmawatch.com/news/LBRX/lb-pharmaceuticals-upcoming-september-investor-events BiopharmaWatch en 2026-09-03T20:05:00.000Z LB Pharmaceuticals to Participate in Upcoming September Investor Events https://www.biopharmawatch.com/news/WVE/wave-life-sciences-cantor-2026-conference BiopharmaWatch en 2026-09-03T20:05:00.000Z Wave Life Sciences to Present at Cantor 2026 Global Healthcare Conference https://www.biopharmawatch.com/news/BSEM/biostem-technologies-hc-wainwright-conference-2026 BiopharmaWatch en 2026-09-03T20:05:00.000Z BioStem Technologies to Present at the H.C. Wainwright 28th Annual Global Investment Conference https://www.biopharmawatch.com/news/SYRE/spyre-therapeutics-september-investor-conferences BiopharmaWatch en 2026-09-03T20:05:00.000Z Spyre Therapeutics to Participate in Upcoming September Investor Conferences https://www.biopharmawatch.com/news/LFCR/lifecore-biomedical-participate-cphi-global-conference BiopharmaWatch en 2026-09-03T20:05:00.000Z Lifecore Biomedical to Participate at CPHI Global Conference https://www.biopharmawatch.com/news/LTGO/latigo-biotherapeutics-q2-2026-results-highlights BiopharmaWatch en 2026-09-03T20:05:00.000Z Latigo Biotherapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights https://www.biopharmawatch.com/news/RNTX/rein-therapeutics-september-investor-conferences BiopharmaWatch en 2026-09-03T20:01:00.000Z Rein Therapeutics to Present at Upcoming September Investor Conferences https://www.biopharmawatch.com/news/XENE/xenon-presents-wells-fargo-healthcare-conference BiopharmaWatch en 2026-09-03T20:01:00.000Z Xenon to Present at Wells Fargo Healthcare Conference https://www.biopharmawatch.com/news/CVS/updated-covid-19-vaccines-cvs-pharmacy-minuteclinic BiopharmaWatch en 2026-09-03T18:00:00.000Z Updated COVID-19 vaccines available at CVS Pharmacy and MinuteClinic across the U.S. https://www.biopharmawatch.com/news/NUS/nu-skin-ranked-worlds-number-one-beauty-wellness-devices BiopharmaWatch en 2026-09-03T15:00:00.000Z Nu Skin Ranked the World’s #1 Company for Beauty and Wellness Device Systems for Third Consecutive Year https://www.biopharmawatch.com/news/MIST/milestone-pharmaceuticals-nmpa-approval-etripamil-china BiopharmaWatch en 2026-09-03T13:35:00.000Z Milestone Pharmaceuticals Announces NMPA Approval of Etripamil Nasal Spray for PSVT in China, Marking First Regulatory Approval of Etripamil Outside of the United States https://www.biopharmawatch.com/news/COSM/cosmos-health-transformation-2026 BiopharmaWatch en 2026-09-03T13:30:00.000Z Cosmos Health: A Company Transformed — 2026 Year-to-Date https://www.biopharmawatch.com/news/ABBV/abbvie-phase-3-cervino-trial-results-etentamig BiopharmaWatch en 2026-09-03T13:15:00.000Z AbbVie Announces Positive Topline Results from the Phase 3 CERVINO Trial Showing Etentamig Significantly Improved Response Rate and Progression-Free Survival in Patients with Relapsed/Refractory Multiple Myeloma https://www.biopharmawatch.com/news/LGVN/longeveron-hc-wainwright-investment-conference-2026 BiopharmaWatch en 2026-09-03T13:15:00.000Z Longeveron to Present at the H.C. Wainwright 28th Annual Global Investment Conference https://www.biopharmawatch.com/news/HCTI/hcti-distributes-minority-interest-teyame-ai-holdings BiopharmaWatch en 2026-09-03T13:05:00.000Z Healthcare Triangle, Inc. to Distribute Minority Interest of Teyame AI Holdings Inc. Common Shares in Stock Dividend Distribution to HCTI Shareholders, In Connection with its Planned Direct Listing. https://www.biopharmawatch.com/news/LIVN/livanova-presents-morgan-stanley-baird-conferences-september BiopharmaWatch en 2026-09-03T13:00:00.000Z LivaNova to Present at Morgan Stanley and Baird Healthcare Conferences in September https://www.biopharmawatch.com/news/CYH/community-health-systems-2026-impact-report BiopharmaWatch en 2026-09-03T13:00:00.000Z Community Health Systems Releases 2026 Community Impact Report https://www.biopharmawatch.com/news/ALC/alcon-launches-unity-m-ophthalmic-microscope BiopharmaWatch en 2026-09-03T13:00:00.000Z Alcon Launches UNITY M, a Premium Ophthalmic Microscope Delivering Precise Control https://www.biopharmawatch.com/news/CODX/co-diagnostics-cloud-infrastructure-india BiopharmaWatch en 2026-09-03T13:00:00.000Z Co-Diagnostics Launches Integrated Cloud and Mobile Infrastructure in India https://www.biopharmawatch.com/news/PALI/palisade-bio-investor-conferences-september-2026 BiopharmaWatch en 2026-09-03T13:00:00.000Z Palisade Bio to Participate in Upcoming Investor Conferences https://www.biopharmawatch.com/news/PLRZ/polyrizon-4-million-offering-private-placement BiopharmaWatch en 2026-09-03T12:50:00.000Z Polyrizon Ltd. Announces $4.0 Million Registered Direct Offering and Private Placement https://www.biopharmawatch.com/news/APGE/abbvie-completes-acquisition-apogee-therapeutics BiopharmaWatch en 2026-09-03T12:34:00.000Z AbbVie Completes Acquisition of Apogee Therapeutics https://www.biopharmawatch.com/news/CTXR/citius-pharmaceuticals-september-2026-investor-conferences BiopharmaWatch en 2026-09-03T12:30:00.000Z Citius Pharmaceuticals to Participate in September 2026 Investor Conferences https://www.biopharmawatch.com/news/TLPH/talphera-hc-wainwright-investment-conference-2026 BiopharmaWatch en 2026-09-03T12:30:00.000Z Talphera to Participate in the H.C. Wainwright 28th Annual Global Investment Conference https://www.biopharmawatch.com/news/FBLG/fibrobiologics-new-patent-fibroblasts-wound-healing BiopharmaWatch en 2026-09-03T12:30:00.000Z FibroBiologics Announces Issuance of New U.S. Patent for the Therapeutic Use of Fibroblasts in Wound Healing https://www.biopharmawatch.com/news/KALA/kala-virotek-exclusive-distribution-agreement BiopharmaWatch en 2026-09-03T12:30:00.000Z Kala Bio and Virotek Finalize Definitive Agreement Establishing Exclusive U.S. Distribution Partnership for Ophthalmology Genetic Testing Program https://www.biopharmawatch.com/news/BBLG/bone-biologics-hc-wainwright-conference-2026 BiopharmaWatch en 2026-09-03T12:30:00.000Z Bone Biologics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference https://www.biopharmawatch.com/news/NXL/nexalin-technology-alzheimers-study-analysis BiopharmaWatch en 2026-09-03T12:30:00.000Z Nexalin Technology Announces New Secondary Analysis of Previously Published Clinical Trial Data Reveals Previously Unreported Improvements in Memory, Comprehension and Language Function in Alzheimer’s Patients; ADAS-Cog Subscale Analysis to Guide Design of Planned U.S. Alzheimer’s Pilot Study https://www.biopharmawatch.com/news/CRVS/corvus-pharmaceuticals-2026-cantor-conference BiopharmaWatch en 2026-09-03T12:30:00.000Z Corvus Pharmaceuticals to Present at the 2026 Cantor Global Healthcare Conference https://www.biopharmawatch.com/news/MDLN/medline-participation-morgan-stanley-healthcare-conference BiopharmaWatch en 2026-09-03T12:30:00.000Z Medline announces participation in the Morgan Stanley 24th Annual Global Healthcare Conference https://www.biopharmawatch.com/news/ONCO/onconetix-acquisition-realbotix-humanoid-robots-pilot BiopharmaWatch en 2026-09-03T12:30:00.000Z Onconetix Acquisition Target Realbotix Launches Pilot with Leading European Telecommunications Company to Deploy Humanoid Robots in Live Presentations and Events https://www.biopharmawatch.com/news/PROF/profound-medical-lake-street-conference-2026 BiopharmaWatch en 2026-09-03T12:15:00.000Z Profound Medical to Participate in Lake Street’s 10th Annual Best Ideas Growth Conference https://www.biopharmawatch.com/news/SRXH/srx-global-armr-sciences-shareholder-update BiopharmaWatch en 2026-09-03T12:15:00.000Z SRX Global Provides Shareholder Update on Portfolio Company, ARMR Sciences, a Clinical-Stage Biodefense Company https://www.biopharmawatch.com/news/ABBV/abbvie-presents-morgan-stanley-healthcare-conference-2026 BiopharmaWatch en 2026-09-03T12:05:00.000Z AbbVie to Present at the Morgan Stanley 24th Annual Global Healthcare Conference https://www.biopharmawatch.com/news/HRMY/harmony-biosciences-poster-presentations-european-epilepsy-congress BiopharmaWatch en 2026-09-03T12:05:00.000Z Harmony Biosciences Announces Poster Presentations at the 16th European Epilepsy Congress https://www.biopharmawatch.com/news/SXTP/60-degrees-pharmaceuticals-hc-wainwright-conference-2026 BiopharmaWatch en 2026-09-03T12:04:00.000Z 60 Degrees Pharmaceuticals Announces Participation in H.C. Wainwright 28th Annual Global Investment Conference https://www.biopharmawatch.com/news/ANIX/anixa-biosciences-nasdaq-ld-micro-summit-2026 BiopharmaWatch en 2026-09-03T12:00:00.000Z Anixa Biosciences to Present at the Nasdaq & LD Micro Inaugural SF Summit on September 9, 2026 https://www.biopharmawatch.com/news/ANIX/anixa-biosciences-presentation-nasdaq-ld-micro-summit BiopharmaWatch en 2026-09-03T12:00:00.000Z Anixa Biosciences to Present at the Nasdaq & LD Micro Inaugural SF Summit on September 9, 2026 https://www.biopharmawatch.com/news/MENS/jyong-biotech-stockfan-virtual-investor-roadshow BiopharmaWatch en 2026-09-03T12:00:00.000Z Jyong Biotech Announces Participation in StockFan Virtual Investor Non-Deal Roadshow https://www.biopharmawatch.com/news/NSPR/inspiremd-hc-wainwright-conference-2026 BiopharmaWatch en 2026-09-03T12:00:00.000Z InspireMD to Participate in Upcoming H.C. Wainwright 28th Annual Global Investment Conference https://www.biopharmawatch.com/news/REPL/replimune-present-cantor-global-healthcare-conference-2026 BiopharmaWatch en 2026-09-03T12:00:00.000Z Replimune to Present at the Cantor Global Healthcare Conference 2026 https://www.biopharmawatch.com/news/TECX/tectonic-therapeutic-morgan-stanley-conference BiopharmaWatch en 2026-09-03T12:00:00.000Z Tectonic Therapeutic to Participate in the Morgan Stanley Global Healthcare Conference https://www.biopharmawatch.com/news/LBRX/lb-pharmaceuticals-appoints-joseph-miller-cfo BiopharmaWatch en 2026-09-03T12:00:00.000Z LB Pharmaceuticals Appoints Joseph Miller as Chief Financial Officer https://www.biopharmawatch.com/news/NVCT/nuvectis-pharma-investor-conferences-2026 BiopharmaWatch en 2026-09-03T12:00:00.000Z Nuvectis Pharma To Participate in Upcoming Investor Conferences https://www.biopharmawatch.com/news/BMEA/biomea-fusion-investor-conferences-2026 BiopharmaWatch en 2026-09-03T12:00:00.000Z Biomea Fusion to Participate in Upcoming Investor Conferences https://www.biopharmawatch.com/news/CVKD/cadrenal-therapeutics-hc-wainwright-conference-2026 BiopharmaWatch en 2026-09-03T12:00:00.000Z Cadrenal Therapeutics to Participate in H.C. Wainwright's 28th Annual Global Investment Conference https://www.biopharmawatch.com/news/OVID/ovid-therapeutics-investor-conferences-2026 BiopharmaWatch en 2026-09-03T12:00:00.000Z Ovid Therapeutics to Participate in Upcoming Investor Conferences https://www.biopharmawatch.com/news/ALT/altimmune-wells-fargo-healthcare-conference-2026 BiopharmaWatch en 2026-09-03T12:00:00.000Z Altimmune to Participate in the Wells Fargo 21st Annual Healthcare Conference https://www.biopharmawatch.com/news/QNCX/quince-therapeutics-september-2026-investor-conferences BiopharmaWatch en 2026-09-03T12:00:00.000Z Quince Therapeutics to Participate in September 2026 Investor Conferences https://www.biopharmawatch.com/news/ACRS/aclaris-therapeutics-2026-cantor-conference BiopharmaWatch en 2026-09-03T12:00:00.000Z Aclaris Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference https://www.biopharmawatch.com/news/KRYS/krystal-biotech-2026-cantor-conference BiopharmaWatch en 2026-09-03T12:00:00.000Z Krystal Biotech to Present at 2026 Cantor Global Healthcare Conference https://www.biopharmawatch.com/news/GRCE/grace-therapeutics-hc-wainwright-conference-2026 BiopharmaWatch en 2026-09-03T12:00:00.000Z Grace Therapeutics to Participate in the H.C. Wainright 28th Annual Global Investment Conference https://www.biopharmawatch.com/news/STXS/university-szeged-robotic-cardiology-program-launch BiopharmaWatch en 2026-09-03T11:56:00.000Z University of Szeged Celebrates Strongest First Month of Robotic Cardiology Program https://www.biopharmawatch.com/news/EBS/emergent-biosolutions-repurchases-senior-unsecured-notes BiopharmaWatch en 2026-09-03T11:45:00.000Z Emergent BioSolutions Completes Repurchase of $75 Million Aggregate Principal Amount of Senior Unsecured Notes https://www.biopharmawatch.com/news/HELP/helus-pharma-cantor-healthcare-conference-2026 BiopharmaWatch en 2026-09-03T11:30:36.000Z Helus Pharma to Participate at the 2026 Cantor Global Healthcare Conference in New York https://www.biopharmawatch.com/news/LQDA/fda-fast-track-yutrepia-raynauds-phenomenon BiopharmaWatch en 2026-09-03T11:30:00.000Z FDA Grants Fast Track Designation to YUTREPIA® for the Treatment of Raynaud's Phenomenon Associated with Systemic Sclerosis https://www.biopharmawatch.com/news/ARWR/arrowhead-pharmaceuticals-september-2026-investor-conferences BiopharmaWatch en 2026-09-03T11:30:00.000Z Arrowhead Pharmaceuticals to Participate in Upcoming September 2026 Investor Conferences https://www.biopharmawatch.com/news/GPCR/structure-therapeutics-upcoming-healthcare-conferences BiopharmaWatch en 2026-09-03T11:30:00.000Z Structure Therapeutics to Participate in Upcoming Healthcare Investor Conferences https://www.biopharmawatch.com/news/DYN/dyne-therapeutics-preclinical-data-dmd-nmsg-meeting BiopharmaWatch en 2026-09-03T11:30:00.000Z Dyne Therapeutics to Present Preclinical Data for Multiple Development Candidates for Duchenne Muscular Dystrophy (DMD) at 27th Annual NMSG Scientific Meeting https://www.biopharmawatch.com/news/EIKN/eikon-therapeutics-appoints-ching-pin-chang-cso BiopharmaWatch en 2026-09-03T11:30:00.000Z Eikon Therapeutics Appoints Ching-Pin Chang, M.D., Ph.D. as Executive Vice President and Chief Scientific Officer https://www.biopharmawatch.com/news/ADCT/adc-therapeutics-2026-cantor-global-healthcare-conference BiopharmaWatch en 2026-09-03T11:15:00.000Z ADC Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference https://www.biopharmawatch.com/news/ATHE/alterity-therapeutics-fireside-chat-cantor-conference-2026 BiopharmaWatch en 2026-09-03T11:05:00.000Z Alterity Therapeutics to Participate in a Fireside Chat at the Cantor Global Healthcare Conference 2026 https://www.biopharmawatch.com/news/CTSO/cytosorbents-reverse-stock-split-nasdaq-compliance BiopharmaWatch en 2026-09-03T11:00:00.000Z CytoSorbents Announces Reverse Stock Split https://www.biopharmawatch.com/news/INSM/insmed-data-presentation-ers-congress-2026 BiopharmaWatch en 2026-09-03T11:00:00.000Z Insmed to Present Data Across Its Respiratory Portfolio, Including New Late-Breaking ARIKAYCE® (amikacin liposome inhalation suspension) Results From Phase 3b ENCORE Study at the European Respiratory Society Congress 2026 https://www.biopharmawatch.com/news/ARMP/armata-pharmaceuticals-phage-biology-publication BiopharmaWatch en 2026-09-03T11:00:00.000Z Armata Pharmaceuticals Announces New Publication That Advances Understanding of Phage Biology to Support Development of Next-Generation Antibacterials https://www.biopharmawatch.com/news/FATE/fate-therapeutics-fireside-chat-2026-cantor-conference BiopharmaWatch en 2026-09-03T11:00:00.000Z Fate Therapeutics to Participate in Fireside Chat at the 2026 Annual Cantor Global Healthcare Conference https://www.biopharmawatch.com/news/ELDN/eledon-pharmaceuticals-islet-cell-transplantation-ind-submission BiopharmaWatch en 2026-09-03T11:00:00.000Z Eledon Pharmaceuticals Announces Islet Cell Transplantation IND Submission, First Patients Enrolled in Multiple Transplant Programs, and Reaffirms Plan to Initiate Phase 3 Kidney Transplantation Trial in Fourth Quarter 2026 https://www.biopharmawatch.com/news/GYRE/gyre-therapeutics-september-investor-conferences BiopharmaWatch en 2026-09-03T11:00:00.000Z Gyre Therapeutics to Participate in Upcoming September Investor Conferences https://www.biopharmawatch.com/news/CCCC/c4-therapeutics-cemsidomide-biomarker-data-presentation BiopharmaWatch en 2026-09-03T11:00:00.000Z C4 Therapeutics to Present New Biomarker Data on the Immunomodulatory Effects of Cemsidomide in Combination with Dexamethasone from its Phase 1 Relapsed/Refractory Multiple Myeloma Trial at the 23rd International Myeloma Society (IMS) Annual Meeting https://www.biopharmawatch.com/news/LONA/leonabio-participate-cantor-global-healthcare-conference-2026 BiopharmaWatch en 2026-09-03T11:00:00.000Z LeonaBio to Participate in Cantor Global Healthcare Conference 2026 https://www.biopharmawatch.com/news/CLYM/climb-bio-clym116-phase-1-data-iga-nephropathy BiopharmaWatch en 2026-09-03T11:00:00.000Z Climb Bio Announces CLYM116 Phase 1 Data Demonstrating Prolonged Half-Life and Best-In-Class APRIL Suppression Supporting Every-12-Week Dosing in IgA Nephropathy https://www.biopharmawatch.com/news/BLSM/blossomhill-therapeutics-conference-presentation BiopharmaWatch en 2026-09-03T11:00:00.000Z BlossomHill Therapeutics to Present at the 8th Annual RAS-Targeted Drug Development Summit & H.C. Wainwright 28th Annual Global Investment Conference https://www.biopharmawatch.com/news/ANIP/ani-pharmaceuticals-september-investor-conferences BiopharmaWatch en 2026-09-03T10:55:00.000Z ANI Pharmaceuticals to Present at September Investor Conferences https://www.biopharmawatch.com/news/PHVS/pharvaris-bradykinin-symposium-2026-data BiopharmaWatch en 2026-09-03T10:50:00.000Z Pharvaris Presents Translational, Nonclinical, and Clinical Data at Bradykinin Symposium 2026 https://www.biopharmawatch.com/news/FTRE/fortrea-worldwide-clinical-trials-partnership BiopharmaWatch en 2026-09-03T07:52:00.000Z Fortrea เข้าซื้อกิจการหน่วยเภสัชวิทยาคลินิกและการปฏิบัติการห้องปฏิบัติการวิเคราะห์ทางชีวภาพจาก Worldwide Clinical Trials https://www.biopharmawatch.com/news/FTRE/fortrea-acquires-early-phase-services-worldwide-clinical-trials BiopharmaWatch en 2026-09-03T07:52:00.000Z Fortrea Akan Mengambil Alih Unit Farmakologi Klinikal dan Operasi Makmal Bioanalisis daripada Worldwide Clinical Trials https://www.biopharmawatch.com/news/FTRE/fortrea-worldwide-clinical-trials-collaboration BiopharmaWatch en 2026-09-03T07:52:00.000Z Fortrea, Worldwide Clinical Trials의 임상약리 유닛·생물분석 연구소 사업 인수 https://www.biopharmawatch.com/news/FTRE/fortrea-acquires-early-phase-services-worldwide BiopharmaWatch en 2026-09-03T07:52:00.000Z Fortrea Akan Mengakuisisi Unit Farmakologi Klinis dan Operasional Laboratorium Bionalitik dari Worldwide Clinical Trials https://www.biopharmawatch.com/news/FTRE/fortrea-acquires-worldwide-clinical-trials-early-phase-services BiopharmaWatch en 2026-09-03T07:52:00.000Z Fortrea acquiert l’unité de pharmacologie clinique et les activités de laboratoire bioanalytique de Worldwide Clinical Trials https://www.biopharmawatch.com/news/BIIB/leqembi-subcutaneous-approval-china BiopharmaWatch en 2026-09-03T04:00:28.000Z LEQEMBI® (lecanemab) Subcutaneous Formulation as an Initiation Treatment for Early Alzheimer’s Disease Approved in China https://www.biopharmawatch.com/news/RVMD/phase-1-2-data-rasonque-nsclc BiopharmaWatch en 2026-09-02T21:50:00.000Z New England Journal of Medicine Publishes Phase 1/2 Clinical Data on Revolution Medicines’ RASONQUE™ (daraxonrasib) in Metastatic Non-Small Cell Lung Cancer https://www.biopharmawatch.com/news/SMMT/ivonescimab-harmoni-2-study-nsclc BiopharmaWatch en 2026-09-02T21:41:00.000Z Ivonescimab Monotherapy Demonstrates Statistically Significant Overall Survival Benefit Compared to Pembrolizumab Monotherapy in PD-L1-Positive Advanced NSCLC in HARMONi-2 Study Conducted by Akeso in China https://www.biopharmawatch.com/news/VCTR/investigation-victory-capital-merger-first-eagle BiopharmaWatch en 2026-09-02T21:32:00.000Z $HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Victory Capital Holdings, Inc. (NASDAQ: VCTR) https://www.biopharmawatch.com/news/SOAR/shareholder-alert-volato-group-investigation BiopharmaWatch en 2026-09-02T21:29:00.000Z $HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Volato Group, Inc. (NYSE American: SOAR) https://www.biopharmawatch.com/news/NVAX/novavax-september-investor-conferences-2026 BiopharmaWatch en 2026-09-02T21:00:00.000Z Novavax to Participate in September Investor Conferences https://www.biopharmawatch.com/news/VNDA/vanda-pharmaceuticals-september-2026-investor-conferences BiopharmaWatch en 2026-09-02T20:51:00.000Z Vanda Pharmaceuticals Announces Participation at September 2026 Investor Conferences https://www.biopharmawatch.com/news/JNJ/johnson-johnson-deutsche-bank-2026-healthcare-summit BiopharmaWatch en 2026-09-02T20:21:00.000Z Johnson & Johnson to Participate in the Deutsche Bank 2026 Healthcare Summit https://www.biopharmawatch.com/news/EW/edwards-lifesciences-deutsche-bank-healthcare-summit BiopharmaWatch en 2026-09-02T20:15:00.000Z Edwards Lifesciences to Present at the Deutsche Bank Healthcare Summit https://www.biopharmawatch.com/news/SLBT/sl-science-holding-nasdaq-bell-ceremony BiopharmaWatch en 2026-09-02T20:10:00.000Z SL Science Holding Limited Rings Nasdaq Bell, Capping an Active First Quarter as a Publicly Traded Company https://www.biopharmawatch.com/news/RCEL/avita-medical-participate-lake-street-morgan-stanley-conferences BiopharmaWatch en 2026-09-02T20:10:00.000Z AVITA Medical to Participate in Lake Street Best Ideas Growth Conference and Morgan Stanley Healthcare Conference https://www.biopharmawatch.com/news/KARD/kardigan-present-september-investor-conferences BiopharmaWatch en 2026-09-02T20:05:00.000Z Kardigan to Present at Two September Investor Conferences https://www.biopharmawatch.com/news/SOLV/solventum-participate-wells-fargo-healthcare-conference BiopharmaWatch en 2026-09-02T20:05:00.000Z Solventum to Participate in the 2026 Wells Fargo Healthcare Conference https://www.biopharmawatch.com/news/IVA/inventiva-nativ3-phase-3-trial-lanifibranor-mash BiopharmaWatch en 2026-09-02T20:05:00.000Z Inventiva Announces Last Patient Visit in NATiV3 Phase 3 Clinical Trial of Lanifibranor in MASH https://www.biopharmawatch.com/news/BLLN/billiontoone-participate-wells-fargo-healthcare-conference BiopharmaWatch en 2026-09-02T20:05:00.000Z BillionToOne to Participate in the Wells Fargo 21st Annual Healthcare Conference https://www.biopharmawatch.com/news/NYXH/nyxoah-access-us-study-results-collapsed-patients BiopharmaWatch en 2026-09-02T20:05:00.000Z Nyxoah Announces ACCCESS U.S. Pivotal Study Meets Primary Safety and Efficacy Endpoints in Complete Concentric Collapse Patients https://www.biopharmawatch.com/news/SCTX/scribe-therapeutics-q2-2026-financial-results BiopharmaWatch en 2026-09-02T20:05:00.000Z Scribe Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights https://www.biopharmawatch.com/news/ELUT/elutia-participate-lake-street-hc-wainwright-conferences BiopharmaWatch en 2026-09-02T20:05:00.000Z Elutia to Participate in the Lake Street Capital Markets 10th Annual Big Ideas Growth Conference & the H.C. Wainwright 28th Annual Global Investment Conference https://www.biopharmawatch.com/news/STTK/shattuck-labs-september-investor-conferences BiopharmaWatch en 2026-09-02T20:05:00.000Z Shattuck Labs Announces Participation in Upcoming September Investor Conferences https://www.biopharmawatch.com/news/OPCH/option-care-health-investor-conferences-2026 BiopharmaWatch en 2026-09-02T20:05:00.000Z Option Care Health to Participate in Upcoming Investor Conferences https://www.biopharmawatch.com/news/RARE/ultragenyx-phase-3-aspire-results-angelman-syndrome BiopharmaWatch en 2026-09-02T20:01:32.000Z Ultragenyx Announces Phase 3 Aspire results in Angelman Syndrome https://www.biopharmawatch.com/news/STAA/staar-surgical-appoints-ben-park-cto BiopharmaWatch en 2026-09-02T20:01:00.000Z STAAR Surgical Names Medtech Innovator and Platform Builder Ben Park as Chief Technology Officer https://www.biopharmawatch.com/news/XNCR/xencor-present-cantor-global-healthcare-conference-2026 BiopharmaWatch en 2026-09-02T20:01:00.000Z Xencor to Present at the 2026 Cantor Global Healthcare Conference https://www.biopharmawatch.com/news/MIRM/mirum-pharmaceuticals-investor-conferences BiopharmaWatch en 2026-09-02T20:01:00.000Z Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences https://www.biopharmawatch.com/news/AMGN/amgen-presents-2026-wells-fargo-healthcare-conference BiopharmaWatch en 2026-09-02T20:01:00.000Z AMGEN TO PRESENT AT THE 2026 WELLS FARGO HEALTHCARE CONFERENCE https://www.biopharmawatch.com/news/NBIX/neurocrine-biosciences-investor-conferences-september-2026 BiopharmaWatch en 2026-09-02T20:01:00.000Z Neurocrine Biosciences to Present at Upcoming Investor Conferences in September https://www.biopharmawatch.com/news/SPRO/spero-therapeutics-presentation-hc-wainwright-conference BiopharmaWatch en 2026-09-02T20:01:00.000Z Spero Therapeutics to Present at H.C. Wainwright 28th Annual Global Investment Conference https://www.biopharmawatch.com/news/BDTX/black-diamond-therapeutics-hc-wainwright-conference-2026 BiopharmaWatch en 2026-09-02T20:01:00.000Z Black Diamond Therapeutics to Participate in H.C. Wainwright 28th Annual Global Investment Conference https://www.biopharmawatch.com/news/AURA/aura-biosciences-investor-conference-participation BiopharmaWatch en 2026-09-02T20:01:00.000Z Aura Biosciences to Participate in Upcoming Investor Conference https://www.biopharmawatch.com/news/ARQT/arcutis-management-morgan-stanley-conference-2026 BiopharmaWatch en 2026-09-02T20:00:29.000Z Arcutis Management to Present at the Morgan Stanley 24th Annual Global Healthcare Conference https://www.biopharmawatch.com/news/VRDN/viridian-therapeutics-wells-fargo-healthcare-conference BiopharmaWatch en 2026-09-02T20:00:00.000Z Viridian Therapeutics to Participate in the Wells Fargo 21st Annual Healthcare Conference https://www.biopharmawatch.com/news/ACET/adicet-bio-fireside-chat-hc-wainwright-conference BiopharmaWatch en 2026-09-02T20:00:00.000Z Adicet Bio to Participate in Fireside Chat at H.C. Wainwright 28th Annual Global Investment Conference https://www.biopharmawatch.com/news/AVXL/anavex-regains-compliance-nasdaq-filing-requirement BiopharmaWatch en 2026-09-02T20:00:00.000Z Anavex Life Sciences Regains Compliance with Nasdaq Periodic Filing Requirement https://www.biopharmawatch.com/news/SLBT/sl-science-holding-nasdaq-debut BiopharmaWatch en 2026-09-02T19:00:11.000Z SL Science Holding Limited 敲響納斯達克開市鐘，上市首季度業務成果豐碩 https://www.biopharmawatch.com/news/SBC/sbc-medical-investor-conferences-september-2026 BiopharmaWatch en 2026-09-02T18:42:00.000Z Riassunto: SBC Medical parteciperà a diverse prossime conferenze per gli investitori nel settembre 2026 https://www.biopharmawatch.com/news/MVST/microvast-holdings-shareholder-losses-contact-law-firm BiopharmaWatch en 2026-09-02T18:34:28.143Z Shareholders who lost money in shares of Microvast Holdings, Inc. (NASDAQ: MVST) Should Contact Wolf Haldenstein Immediately https://www.biopharmawatch.com/news/SBC/sbc-medical-investor-conferences-september-2026 BiopharmaWatch en 2026-09-02T18:34:00.000Z SBC Medical participera à plusieurs conférences d'investisseurs en septembre 2026 https://www.biopharmawatch.com/news/AARD/aardvark-therapeutics-shareholder-losses BiopharmaWatch en 2026-09-02T18:33:54.280Z Shareholders who lost money in shares of acquired Aardvark Therapeutics, Inc. (NASDAQ: AARD) should contact Wolf Haldenstein Immediately https://www.biopharmawatch.com/news/SBC/sbc-medical-investor-conferences-september-2026 BiopharmaWatch en 2026-09-02T18:22:00.000Z Resumen: SBC Medical participará en varias conferencias para inversores en septiembre de 2026 https://www.biopharmawatch.com/news/SBC/sbc-medical-investor-conferences-september-2026 BiopharmaWatch en 2026-09-02T17:47:00.000Z SBC Medical wird im September 2026 an mehreren bevorstehenden Investorenkonferenzen teilnehmen https://www.biopharmawatch.com/news/SBC/sbc-medical-investor-conferences-september-2026 BiopharmaWatch en 2026-09-02T17:37:00.000Z Samenvatting: SBC Medical neemt in september 2026 aan verschillende komende investeerdersconferenties deel https://www.biopharmawatch.com/news/HYLN/hyliion-class-action-lawsuit-investigation BiopharmaWatch en 2026-09-02T16:07:00.000Z Berger Montague PC Investigating Claims on Behalf of Investors in Hyliion Holdings Corp. (NYSE: HYLN) After Class Action Filing https://www.biopharmawatch.com/news/CWEB/charlottes-web-congressional-action-continuing-resolution BiopharmaWatch en 2026-09-02T15:07:00.000Z Charlotte's Web Applauds Congressional Action to Advance Continuing Resolution https://www.biopharmawatch.com/news/CYH/community-health-systems-wells-fargo-conference-2026 BiopharmaWatch en 2026-09-02T15:00:00.000Z Community Health Systems to Participate in the Wells Fargo 21st Annual Healthcare Conference https://www.biopharmawatch.com/news/MOH/molina-healthcare-q3-2026-earnings-release BiopharmaWatch en 2026-09-02T13:00:00.000Z Molina Healthcare Announces Third Quarter 2026 Earnings Release and Conference Call Dates https://www.biopharmawatch.com/news/HCWB/hcw-biologics-strengthens-patent-hcw9302-alopecia-areata BiopharmaWatch en 2026-09-02T13:00:00.000Z HCW Biologics Strengthens U.S. Patent Estate for Its Lead Clinical-Stage Immunotherapeutic HCW9302 as Alopecia Areata Treatment https://www.biopharmawatch.com/news/AIM/aim-immunotech-expands-ampligen-patent-protection-long-covid BiopharmaWatch en 2026-09-02T12:43:00.000Z AIM ImmunoTech Significantly Expands Ampligen® Global Patent Estate with Long COVID Protection Across Europe and the United Kingdom Through 2041 https://www.biopharmawatch.com/news/NAGE/niagen-bioscience-longevity-investors-conference-2026 BiopharmaWatch en 2026-09-02T12:32:00.000Z Niagen Bioscience to Present at Longevity Investors Conference https://www.biopharmawatch.com/news/COCH/envoy-medical-hc-wainwright-conference-2026 BiopharmaWatch en 2026-09-02T12:30:00.000Z Envoy Medical to Present at the H.C. Wainwright 28th Annual Global Investment Conference on September 14th-16th https://www.biopharmawatch.com/news/LQDA/liquidia-present-posters-ers-2026-congress BiopharmaWatch en 2026-09-02T12:30:00.000Z Liquidia to Present Posters at the European Respiratory Society (ERS) 2026 Congress https://www.biopharmawatch.com/news/DMAC/diamedica-therapeutics-investor-conferences-september-2026 BiopharmaWatch en 2026-09-02T12:30:00.000Z DiaMedica Therapeutics to Participate in Upcoming September Investor Conferences https://www.biopharmawatch.com/news/COR/cencora-accelerate-pharmacy-solutions-cell-gene-therapy BiopharmaWatch en 2026-09-02T12:30:00.000Z Cencora’s Accelerate Pharmacy Solutions Launches Cell and Gene Therapy Enablement to Help Health Systems Build and Scale Programs https://www.biopharmawatch.com/news/CAI/caris-life-sciences-precision-oncology-iaslc-2026 BiopharmaWatch en 2026-09-02T12:30:00.000Z Caris Life Sciences to Present New Research Advancing Precision Oncology at the IASLC 2026 World Conference on Lung Cancer https://www.biopharmawatch.com/news/HALO/halozyme-investor-conferences-september-2026 BiopharmaWatch en 2026-09-02T12:30:00.000Z Halozyme to Participate at Upcoming Investor Conferences https://www.biopharmawatch.com/news/ARTV/artiva-biotherapeutics-investor-conferences-september-2026 BiopharmaWatch en 2026-09-02T12:30:00.000Z Artiva Biotherapeutics to Participate in Upcoming Investor Conferences in September https://www.biopharmawatch.com/news/VERU/veru-fireside-chat-2026-cantor-conference BiopharmaWatch en 2026-09-02T12:30:00.000Z Veru to Participate in Fireside Chat at the 2026 Cantor Global Healthcare Conference https://www.biopharmawatch.com/news/RNXT/renovorx-presentation-hc-wainwright-conference-2026 BiopharmaWatch en 2026-09-02T12:30:00.000Z RenovoRx to Present at H.C. Wainwright 28th Annual Global Investment Conference, September 14th-16th https://www.biopharmawatch.com/news/FEED/envue-medical-exhibit-navigation-platform-vizient-exchange BiopharmaWatch en 2026-09-02T12:30:00.000Z ENvue Medical Selected to Exhibit ENvue™ Navigation Platform at Vizient Innovative Technology Exchange https://www.biopharmawatch.com/news/SLS/sellas-life-sciences-sls009-preclinical-data-aacr-conference BiopharmaWatch en 2026-09-02T12:30:00.000Z SELLAS Life Sciences to Present Preclinical Data on SLS009 in Pancreatic Ductal Adenocarcinoma at the 2026 AACR Conference on Pancreatic Cancer https://www.biopharmawatch.com/news/ALLO/allogene-therapeutics-cfo-retirement-geoffrey-parker BiopharmaWatch en 2026-09-02T12:30:00.000Z Allogene Therapeutics Announces Retirement of Chief Financial Officer Geoffrey Parker https://www.biopharmawatch.com/news/SPRC/scisparc-neurothera-fda-orphan-drug-designation-tourette-syndrome BiopharmaWatch en 2026-09-02T12:17:00.000Z SciSparc: Subsidiary NeuroThera Labs Pursues FDA Orphan Drug Designation For Adult Tourette Syndrome Drug; Engages Government and Public Affairs Firm RK Strategies https://www.biopharmawatch.com/news/ACRV/acrivon-therapeutics-presentation-cantor-conference-2026 BiopharmaWatch en 2026-09-02T12:00:28.000Z Acrivon Therapeutics to Present at the 2026 Cantor Global Healthcare Conference https://www.biopharmawatch.com/news/APPT/apptly-commences-trading-otcqb-dtc-eligible BiopharmaWatch en 2026-09-02T12:00:00.000Z Apptly Commences Trading on the OTCQB and Becomes DTC Eligible https://www.biopharmawatch.com/news/ARDT/ardent-health-expansion-specialty-care-ut-tyler BiopharmaWatch en 2026-09-02T12:00:00.000Z Ardent Health Marks Expansion of Specialty Care in New UT Tyler School of Medicine https://www.biopharmawatch.com/news/THC/tenet-participate-wells-fargo-healthcare-conference BiopharmaWatch en 2026-09-02T12:00:00.000Z Tenet to Participate in the Wells Fargo Healthcare Conference https://www.biopharmawatch.com/news/ARGX/benchsci-argenx-agreement-preclinical-drug-discovery BiopharmaWatch en 2026-09-02T12:00:00.000Z BenchSci Announces Two-Year Enterprise Agreement with argenx to Advance AI-Driven Preclinical Drug Discovery https://www.biopharmawatch.com/news/STOK/stoke-therapeutics-cantor-global-healthcare-conference BiopharmaWatch en 2026-09-02T12:00:00.000Z Stoke Therapeutics to Present at the Cantor Global Healthcare Conference https://www.biopharmawatch.com/news/ALNY/alnylam-webcast-presentations-september-conferences BiopharmaWatch en 2026-09-02T12:00:00.000Z Alnylam to Webcast Presentations at Upcoming September Investor Conferences https://www.biopharmawatch.com/news/SRRK/scholar-rock-fda-fast-track-apitegromab-fshd-phase-2 BiopharmaWatch en 2026-09-02T12:00:00.000Z Scholar Rock Receives FDA Fast Track Designation for Apitegromab Facioscapulohumeral Muscular Dystrophy (FSHD) Program as Participant Dosing Commences in Phase 2 FORGE Trial https://www.biopharmawatch.com/news/SLN/silence-therapeutics-september-investor-conferences BiopharmaWatch en 2026-09-02T12:00:00.000Z Silence Therapeutics to Participate in Three September Investor Conferences https://www.biopharmawatch.com/news/RNA/atrium-therapeutics-investor-conferences-september-2026 BiopharmaWatch en 2026-09-02T12:00:00.000Z Atrium Therapeutics to Participate in Upcoming Investor Conferences https://www.biopharmawatch.com/news/TRLV/trulieve-september-2026-event-participation BiopharmaWatch en 2026-09-02T12:00:00.000Z Trulieve Announces September 2026 Event Participation https://www.biopharmawatch.com/news/MDGL/madrigal-pharmaceuticals-2026-cantor-healthcare-conference BiopharmaWatch en 2026-09-02T12:00:00.000Z Madrigal Pharmaceuticals to Participate in the  2026 Cantor Global Healthcare Conference https://www.biopharmawatch.com/news/DSGN/design-therapeutics-2026-cantor-fitzgerald-conference BiopharmaWatch en 2026-09-02T12:00:00.000Z Design Therapeutics to Participate in 2026 Cantor Fitzgerald Global Healthcare Conference https://www.biopharmawatch.com/news/XAIR/beyond-air-participate-2026-cantor-healthcare-conference BiopharmaWatch en 2026-09-02T12:00:00.000Z Beyond Air to Participate in the 2026 Cantor Global Healthcare Conference https://www.biopharmawatch.com/news/ALGS/aligos-therapeutics-cantor-global-healthcare-conference BiopharmaWatch en 2026-09-02T12:00:00.000Z Aligos Therapeutics to Present at the Cantor Global Healthcare Conference https://www.biopharmawatch.com/news/MIST/milestone-pharmaceuticals-investor-conferences-2026 BiopharmaWatch en 2026-09-02T12:00:00.000Z Milestone Pharmaceuticals to Present at Upcoming Investor Conferences https://www.biopharmawatch.com/news/IMDX/imdx-participate-lake-street-big10-conference BiopharmaWatch en 2026-09-02T12:00:00.000Z iMDx to Participate in Lake Street 10th Annual Best Ideas Growth “BIG10” Conference https://www.biopharmawatch.com/news/PRQR/proqr-investor-conferences-september-2026 BiopharmaWatch en 2026-09-02T12:00:00.000Z ProQR to Participate in Upcoming Investor Conferences in September 2026 https://www.biopharmawatch.com/news/ALXO/alx-oncology-investor-conferences-september-2026 BiopharmaWatch en 2026-09-02T12:00:00.000Z ALX Oncology to Present at Upcoming Investor Conferences in September https://www.biopharmawatch.com/news/NAMS/newamsterdam-pharma-investor-conferences-september-2026 BiopharmaWatch en 2026-09-02T12:00:00.000Z NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in September https://www.biopharmawatch.com/news/ANNX/annexon-september-investor-conferences-2026 BiopharmaWatch en 2026-09-02T12:00:00.000Z Annexon to Participate in Upcoming September Investor Conferences https://www.biopharmawatch.com/news/GERN/geron-present-upcoming-investor-conferences BiopharmaWatch en 2026-09-02T12:00:00.000Z Geron to Present at Upcoming Investor Conferences https://www.biopharmawatch.com/news/AAPG/ascentage-pharma-investor-conferences-2026 BiopharmaWatch en 2026-09-02T12:00:00.000Z Ascentage Pharma to Participate in Four Upcoming Investor Conferences https://www.biopharmawatch.com/news/VTVT/vtv-therapeutics-september-investor-conferences BiopharmaWatch en 2026-09-02T12:00:00.000Z vTv Therapeutics to Participate in September Investor Conferences https://www.biopharmawatch.com/news/CGON/cg-oncology-investor-conferences-september-2026 BiopharmaWatch en 2026-09-02T12:00:00.000Z CG Oncology to Present at Upcoming Investor Conferences in September https://www.biopharmawatch.com/news/IMNM/immunome-presents-hc-wainwright-investment-conference BiopharmaWatch en 2026-09-02T11:45:00.000Z Immunome to Present at the H.C. Wainwright 28th Annual Global Investment Conference https://www.biopharmawatch.com/news/PLRZ/polyrizon-completes-us-site-contracts-nasarix-allergy-study BiopharmaWatch en 2026-09-02T11:32:00.000Z Polyrizon Completes All Five U.S. Site Contracts for NASARIX™ First-in-Human Allergy Study https://www.biopharmawatch.com/news/VSTM/verastem-oncology-september-investor-conferences BiopharmaWatch en 2026-09-02T11:30:00.000Z Verastem Oncology to Participate in Upcoming September Investor Conferences https://www.biopharmawatch.com/news/ZTS/zoetis-participate-morgan-stanley-healthcare-conference BiopharmaWatch en 2026-09-02T11:30:00.000Z Zoetis to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference https://www.biopharmawatch.com/news/CRON/cronos-spinach-expands-edibles-vapes BiopharmaWatch en 2026-09-02T11:30:00.000Z Cronos’ brand Spinach® Expands its Best-Selling Lineups of Edibles and Vapes https://www.biopharmawatch.com/news/BBIO/bridgebio-new-data-infigratinib-achondroplasia-espe-2026 BiopharmaWatch en 2026-09-02T11:30:00.000Z BridgeBio to Present New Data on the Impact of Oral Infigratinib on Medical Complications in Achondroplasia at the Annual ESPE Meeting 2026 https://www.biopharmawatch.com/news/KYNB/kyntra-bio-presentation-hc-wainwright-conference-2026 BiopharmaWatch en 2026-09-02T11:30:00.000Z Kyntra Bio to Present at the H.C. Wainwright 28th Annual Global Investment Conference https://www.biopharmawatch.com/news/PVLA/palvella-therapeutics-investor-conferences-2026 BiopharmaWatch en 2026-09-02T11:30:00.000Z Palvella Therapeutics to Participate in Upcoming Healthcare Investor Conferences https://www.biopharmawatch.com/news/ZVRA/zevra-therapeutics-investor-conferences-2026 BiopharmaWatch en 2026-09-02T11:30:00.000Z Zevra Therapeutics to Present at Upcoming Investor Conferences https://www.biopharmawatch.com/news/CTSO/cytosorbents-reduces-severe-bleeding-cabg-patients BiopharmaWatch en 2026-09-02T11:28:00.000Z CytoSorbents Announces New Real-World Data Demonstrating Significant Reduction in Severe Bleeding Using CytoSorb in CABG Patients on Ticagrelor and Updates Recent DrugSorb-ATR FDA Pre-Submission Meetings https://www.biopharmawatch.com/news/ACB/reject-curaleaf-bid-aurora-cannabis BiopharmaWatch en 2026-09-02T11:05:00.000Z Aurora Cannabis Urges Shareholders to REJECT Curaleaf's Hostile Bid, Warning that it is Inadequate, Undervalues Aurora and Puts Shareholder Value and Future Upside at Risk https://www.biopharmawatch.com/news/LFCR/lifecore-biomedical-agreement-commercial-site-transfer BiopharmaWatch en 2026-09-02T11:05:00.000Z Lifecore Biomedical Signs Agreement for Commercial Site Transfer Supporting Global Pharmaceutical Company https://www.biopharmawatch.com/news/QURE/uniqure-bla-ma-submission-huntingtons-disease BiopharmaWatch en 2026-09-02T11:05:00.000Z uniQure Announces Submission of Biologics License Application for Ifezuntirgene Inilparvovec (AMT-130) in Huntington’s Disease https://www.biopharmawatch.com/news/CANF/can-fite-namodenoson-phase-iii-liver-cancer-study BiopharmaWatch en 2026-09-02T11:00:00.000Z Can-Fite Reports Longer-Than-Anticipated Overall Survival in Ongoing Pivotal Phase III Liver Cancer Study https://www.biopharmawatch.com/news/BLCO/bausch-lomb-envista-aspire-research BiopharmaWatch en 2026-09-02T11:00:00.000Z Bausch + Lomb Announces New Published Research on enVista Aspire™ Real World Experience https://www.biopharmawatch.com/news/NVCR/novocure-upcoming-investor-events BiopharmaWatch en 2026-09-02T11:00:00.000Z Novocure Announces Upcoming Investor Events https://www.biopharmawatch.com/news/UTHR/fda-acceptance-snda-nebulized-tyvaso-ipf BiopharmaWatch en 2026-09-02T11:00:00.000Z United Therapeutics Corporation Announces FDA Acceptance of Supplemental New Drug Application for Nebulized Tyvaso® to Treat Idiopathic Pulmonary Fibrosis https://www.biopharmawatch.com/news/NVS/alteogen-novartis-license-agreement-hybrozyme BiopharmaWatch en 2026-09-02T11:00:00.000Z Alteogen Enters Option and License Agreement with Novartis for Development and Commercialization of Hybrozyme™-Enabled Subcutaneous Products https://www.biopharmawatch.com/news/MAZE/maze-therapeutics-investor-conferences-september-2026 BiopharmaWatch en 2026-09-02T11:00:00.000Z Maze Therapeutics to Participate in Three Upcoming Investor Conferences https://www.biopharmawatch.com/news/TNXP/tonix-pharmaceuticals-cantor-2026-healthcare-conference BiopharmaWatch en 2026-09-02T11:00:00.000Z Tonix Pharmaceuticals to Participate in Cantor’s 2026 Global Healthcare Conference https://www.biopharmawatch.com/news/TCRX/tscan-therapeutics-strategic-reorganization-solid-tumors BiopharmaWatch en 2026-09-02T11:00:00.000Z TScan Therapeutics Announces Strategic Reorganization to Focus on in vivo Cell Therapy for Solid Tumors https://www.biopharmawatch.com/news/MDWD/mediwound-presents-hc-wainwright-conference-2026 BiopharmaWatch en 2026-09-02T11:00:00.000Z MediWound to Present at the H.C. Wainwright 28th Annual Global Investment Conference https://www.biopharmawatch.com/news/LXEO/lexeo-therapeutics-investor-conferences-september-2026 BiopharmaWatch en 2026-09-02T11:00:00.000Z Lexeo Therapeutics to Participate in Upcoming Investor Conferences in September https://www.biopharmawatch.com/news/CRDF/cardiff-oncology-participate-september-2026-conferences BiopharmaWatch en 2026-09-02T11:00:00.000Z Cardiff Oncology to Participate in September 2026 Conferences https://www.biopharmawatch.com/news/EYPT/eyepoint-participation-investor-conferences-scientific-meeting BiopharmaWatch en 2026-09-02T11:00:00.000Z EyePoint Announces Participation at Upcoming Investor Conferences and Scientific Meeting https://www.biopharmawatch.com/news/FTRE/fortrea-acquires-early-phase-services-worldwide BiopharmaWatch en 2026-09-02T11:00:00.000Z Fortrea to Acquire Clinical Pharmacology Unit and Bioanalytical Laboratory Operations from Worldwide Clinical Trials https://www.biopharmawatch.com/news/IRD/opus-genetics-opgx-best1-clinical-data-presentation BiopharmaWatch en 2026-09-02T11:00:00.000Z Opus Genetics to Present OPGx-BEST1 Cohort 1 Clinical Data in Investor Webcast and at Upcoming Leading Ophthalmology Conferences https://www.biopharmawatch.com/news/MRK/merck-participate-wells-fargo-healthcare-conference BiopharmaWatch en 2026-09-02T10:45:00.000Z Merck to Participate in the Wells Fargo 21st Annual Healthcare Conference https://www.biopharmawatch.com/news/IMUX/immunic-virtual-rd-day-relapsing-ms-september-2026 BiopharmaWatch en 2026-09-02T10:30:00.000Z Immunic to Host Virtual Relapsing Multiple Sclerosis R&D Day on September 9, 2026 https://www.biopharmawatch.com/news/CMPS/compass-pathways-fierce-50-honoree-2026 BiopharmaWatch en 2026-09-02T10:30:00.000Z Compass Pathways Recognized as a 2026 Fierce 50 Breakthrough Honoree https://www.biopharmawatch.com/news/IMUX/immunic-virtual-rd-day-relapsing-ms-september-2026 BiopharmaWatch en 2026-09-02T10:30:00.000Z Immunic to Host Virtual Relapsing Multiple Sclerosis R&D Day on September 9, 2026 https://www.biopharmawatch.com/news/ENSC/ensysce-biosciences-conference-participation BiopharmaWatch en 2026-09-02T08:30:00.000Z Ensysce Biosciences Announces Upcoming Conference and Industry Event Participation https://www.biopharmawatch.com/news/MDT/cornerstone-robotics-medtronic-partnership-robotic-surgery BiopharmaWatch en 2026-09-02T07:36:00.000Z Cornerstone Robotics gibt strategische Partnerschaft mit Medtronic bekannt, um den weltweiten Zugang zu robotergestützter Chirurgie zu erweitern https://www.biopharmawatch.com/news/PTGX/protagonist-therapeutics-investment-conferences-september-2026 BiopharmaWatch en 2026-09-02T07:05:00.000Z Protagonist Therapeutics to Participate in Two Investment Bank Conferences in September 2026 https://www.biopharmawatch.com/news/EVO/evotec-plectonic-collaboration-tcell-solid-tumors BiopharmaWatch en 2026-09-02T06:04:00.000Z Evotec and Plectonic Enter Research Collaboration to Explore New Generation of T-Cell-Engaging Approaches for Solid Tumors https://www.biopharmawatch.com/news/IPHA/innate-pharma-hc-wainwright-conference-2026 BiopharmaWatch en 2026-09-02T05:00:00.000Z Innate Pharma to Participate in the H.C. Wainwright 28th Annual Global Investment Conference https://www.biopharmawatch.com/news/MDT/cornerstone-robotics-medtronic-strategic-alliance BiopharmaWatch en 2026-09-02T04:48:00.000Z Cornerstone Robotics anuncia una alianza estratégica con Medtronic https://www.biopharmawatch.com/news/MDT/cornerstone-robotics-medtronic-partnership-robotic-surgery BiopharmaWatch en 2026-09-02T02:45:00.000Z Cornerstone Robotics ogłasza strategiczne partnerstwo z Medtronic mające na celu zwiększenie dostępu do chirurgii robotycznej na świecie https://www.biopharmawatch.com/news/NUTX/nutex-health-data-breach-investigation BiopharmaWatch en 2026-09-02T01:56:00.000Z Nutex Health Data Breach: Edelson Lechtzin LLP Investigates Theft of Patient and Employee Data https://www.biopharmawatch.com/news/ZEPP/zepp-health-q2-2026-financial-results BiopharmaWatch en 2026-09-02T01:00:00.000Z Zepp Health Corporation Reports Second Quarter of 2026 Unaudited Financial Results https://www.biopharmawatch.com/news/ARLO/investigation-arlo-technologies-fiduciary-duties BiopharmaWatch en 2026-09-01T23:50:00.000Z SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duties by Certain Officers and Directors of Arlo Technologies, Inc. (NYSE: ARLO) https://www.biopharmawatch.com/news/ONTO/investigation-onto-innovation-breach-fiduciary-duties BiopharmaWatch en 2026-09-01T23:50:00.000Z SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duties by Certain Officers and Directors of Onto Innovation Inc. (NYSE: ONTO) https://www.biopharmawatch.com/news/TLX/telix-completes-enrollment-phase-3-bipass-study BiopharmaWatch en 2026-09-01T22:18:00.000Z Telix Completes Enrollment in Phase 3 BiPASS Study, Aligns with FDA on NDA Pathway https://www.biopharmawatch.com/news/PNTG/pennant-group-2026-jefferies-healthcare-conference BiopharmaWatch en 2026-09-01T22:07:00.000Z Pennant Group to Participate in the 2026 Jefferies Healthcare Services Conference